ESR1 and breast carcinoma: Furthermore, according to the data retrieved from TCGA database (Supplementary Data 1), lower expression of SERPINA3 is specifically correlated with poorer prognosis in both luminal A and luminal B subtypes of ER+ breast cancer (Fig. 2h, i), but not ER- subtype (Supplementary Fig. 1).